AstraZeneca
AZNCF | OTC
$189.90
-$2.60 (-1.35%)
At close: Mar 13, 2026, 9:30 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 29, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 2.49B | 3.91B | 2.63B | 2.53B | 3.13B | 2.92B | 1.67B | 1.83B | 2.4B | 2.8B | 897M | 1.65B | 2.09B | 2.26B | 778M | 923M | 247M | 553M | -636M | -2B | 764M | 1.61B |
Depreciation & Amortization | 1.92B | 1.37B | 1.51B | 1.55B | 1.39B | 1.28B | 714M | 1.82B | 1.28B | 1.26B | 874M | 1.28B | 1.28B | 1.5B | 1.48B | 1.33B | 1.36B | 1.31B | 2.19B | 2.79B | 753M | 797M |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 579M | n/a | n/a | n/a | 619M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -436.05M | -1B | -1.2B | 835M | -345M | -426M | -350M | 41M | -129M | -455M | -150M | 897M | -989M | 242M | -2.29B | 1.07B | 587M | 1.8B | -2.06B | 1.21B | -353M | 1.21B |
Other Non-Cash Items | -1.07B | -921M | -597M | 217M | -785M | -61M | 877M | -303M | -462M | -1.11B | 459M | -717M | -657M | -873M | -159M | -394M | -943M | -434M | 1.31B | -274M | -272M | -1.68B |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -579M | n/a | n/a | n/a | -619M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -436.05M | -1B | -1.2B | 835M | -345M | -426M | -350M | 41M | -129M | -455M | 150M | 897M | -989M | 242M | 299M | 1.07B | 587M | 1.8B | -1.45B | 1.21B | -353M | 1.21B |
Operating Cash Flow | 2.91B | 3.36B | 2.34B | 5.13B | 3.39B | 3.71B | 2.91B | 3.38B | 3.09B | 2.49B | 2.38B | 3.11B | 1.72B | 3.13B | 2.4B | 2.93B | 1.25B | 3.23B | 1.42B | 1.72B | 892M | 1.93B |
Capital Expenditures | -757.64M | -1.54B | -1.29B | -1.73B | -1.92B | -969M | -955M | -1.36B | -668M | -1.61B | -946M | -879M | -483M | -1.47B | -554M | -1.11B | -543M | -363M | -718M | -660M | -353M | -469M |
Cash Acquisitions | -29.17M | -281M | -273M | -338M | -267M | -362M | -274M | -281M | -2.3B | -940M | -296M | -273M | -184M | -426M | -189M | -342M | -288M | -242M | -218M | -9.63B | -138M | 550M |
Purchase of Investments | 39.48M | -93M | -11M | -30M | -188M | n/a | n/a | -29M | 31M | -98M | -15M | -95M | -26M | n/a | 190M | -321M | -24M | -4M | 6M | -180M | -10M | 249M |
Sales Maturities Of Investments | 2.98M | n/a | 9M | 7M | 114M | 1M | -32M | 47M | 84M | 9M | 97M | -68M | 81M | 19M | n/a | -2M | -9M | 53M | -15M | -15M | 107M | 28M |
Other Investing Acitivies | 119.09M | -871M | -135M | -954M | -1.11B | -463M | -167M | -834M | -308M | -967M | 83M | 94M | 92M | 631M | 304M | 33M | 64M | 388M | 32M | 18M | 158M | 197M |
Investing Cash Flow | -2.95B | -1.79B | -1.45B | -2B | -2.11B | -1.25B | -1.18B | -1.51B | -2.87B | -2.41B | -1.08B | -1.22B | -520M | -1.25B | -249M | -1.74B | -800M | -168M | -913M | -10.46B | -236M | 555M |
Debt Repayment | -2.44B | 4.23B | -3.02B | -356M | 632M | 1.1B | -608M | -2.42B | -1.13B | 5.97B | -236M | -1.21B | -1.44B | 1.92B | -72M | 58M | -1.24B | 297M | -853M | 1.6B | -668M | -194M |
Common Stock Repurchased | -46.63M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -6.38M | -3.29B | -3M | -1.61B | -10M | -3.35B | -3M | -1.58B | -17M | -3.03B | -2M | -1.41B | -22M | -3.05B | n/a | -1.39B | n/a | -2.97B | n/a | -1.39B | n/a | -2.47B |
Other Financial Acitivies | -87.55M | -72M | -268M | -92M | -105M | 23M | -83M | -59M | -76M | -915M | -74M | -111M | -62M | -907M | -304M | -98M | -60M | -1.07B | -217M | -68M | 7.96B | -73M |
Financial Cash Flow | -2.57B | 267M | -3.28B | -2.07B | 518M | -2.71B | -671M | -4.13B | -1.22B | 2.03B | -291M | -2.73B | -1.52B | -2.03B | -358M | -1.43B | -1.3B | -3.74B | -1.05B | 142M | 7.29B | -2.73B |
Net Cash Flow | -2.73B | 1.82B | -2.38B | 1.05B | 1.83B | -222M | 994M | -2.24B | -1.02B | 2.06B | 1.02B | -852M | -357M | -155M | 1.8B | -294M | -873M | -685M | -535M | -8.62B | 7.96B | -309M |
Free Cash Flow | 2.15B | 1.82B | 1.06B | 3.41B | 1.46B | 2.74B | 1.95B | 2.03B | 2.42B | 881M | 1.43B | 2.24B | 1.24B | 1.66B | 1.84B | 1.82B | 705M | 2.87B | 700M | 1.06B | 539M | 1.47B |
Adj. Free Cash Flow | 2.15B | 1.82B | 1.06B | 3.41B | 1.46B | 2.74B | 1.95B | 2.03B | 2.42B | 881M | 855M | 2.24B | 1.24B | 1.66B | 1.23B | 1.82B | 705M | 2.87B | 700M | 1.06B | 539M | 1.47B |
Maintenance CapEx | -757.64M | -1.37B | -1.05B | -1.42B | -1.46B | -616.35M | -363.18M | -602.39M | -297.68M | -1.22B | -806.6M | -683.79M | -174.03M | -1.47B | -554M | -917.64M | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | -172M | -241.81M | -307M | -466.85M | -352.65M | -591.82M | -755.61M | -370.32M | -383.95M | -139.4M | -195.21M | -308.97M | n/a | n/a | -193.36M | -543M | -363M | -718M | -660M | -353M | -469M |
Owner Earnings | 2.15B | 1.99B | 1.3B | 3.71B | 1.93B | 3.1B | 2.54B | 2.78B | 2.79B | 1.26B | 1.57B | 2.43B | 1.54B | 1.66B | 1.84B | 2.01B | 1.25B | 3.23B | 1.42B | 1.72B | 892M | 1.93B |
Add to Watchlist
Select watchlists to add or remove AZNCF